Véronique Sgambato (Principal Investigator)

Email: veronique.sgambato@inserm.fr
Phone: (334) 37 91 12 49

Articles

• R.Cirillo, S.Duperrier, P.Parekh, M.Millot, Q.Li, M.Thiolat, M.Morelli, J.Xie, D.Le Bars, J.Redouté, E.Bezard, V.Sgambato
  Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia
  Journal of Parkinsons Disease, 261267, Vol: 14, (2024), doi: 10.3233/jpd-230331
• Sgambato, Véronique
  The Serotonin 4 Receptor Subtype: A Target of Particular Interest, Especially for Brain Disorders
  International Journal of Molecular Sciences, 5245, Vol: 25, (2024), doi: 10.3390/ijms25105245
• Sandra Duperrier, Analia Bortolozzi, Vèronique Sgambato
  Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson's Disease
  International Journal of Molecular Sciences, 8586, Vol: 23, (2022), doi: 10.3390/ijms23158586
• Cristina Miguelez, Philippe De Deurwaerdére, Vèronique Sgambato
  Editorial: Non-Dopaminergic Systems in Parkinson's Disease
  Frontiers in Pharmacology, Vol: 11, (2020), doi: 10.3389/fphar.2020.593822
• Kathy Dujardin, Vèronique Sgambato
  Neuropsychiatric Disorders in Parkinson's Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
  Frontiers in Neuroscience, Vol: 14, (2020), doi: 10.3389/fnins.2020.00025
• Mathilde Millot, Yosuke Saga, Sandra Duperrier, Elise Mètèreau, Maude Beaudoin-Gobert, Vèronique Sgambato
  Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys
  Neurobiology of Disease, 104643, Vol: 134, (2020), doi: 10.1016/j.nbd.2019.104643
• Vèronique Sgambato
  Blood Flow as a Route for Bidirectional Propagation of Synucleinopathy in Parkinson's Disease?
  Movement Disorders, 1751--1751, Vol: 35, (2020), doi: 10.1002/mds.28236
• Sgambato V.
  Breathing new life into neurotoxic-based monkey models of Parkinson's disease to study the complex biological interplay between serotonin and dopamine. In: 5-HT interaction with other neurotransmitters: experimental evidence and therapeutic relevance (Di Giovanni G and De Deurwaeredere P, Eds)
  Progress in Brain Research, (2020)
• Maude Beaudoin-Gobert, Elise Mètèreau, Sandra Duperrier, Stèphane Thobois, Lèon Tremblay, Vèronique Sgambato
  Pathophysiology of levodopa-induced dyskinesia: Insights from multimodal imaging and immunohistochemistry in non-human primates
  NeuroImage, 132--141, Vol: 183, (2018), doi: 10.1016/j.neuroimage.2018.08.016
• Stephane Thobois, Christine Brefel-Courbon, Didier Le Bars, Vèronique Sgambato-Faure
  Molecular Imaging of Opioid System in Idiopathic Parkinson's Disease
  275--303, (2018), doi: 10.1016/bs.irn.2018.07.029
• Vèronique Sgambato, Lèon Tremblay
  Pathophysiology of dyskinesia and behavioral disorders in non-human primates: the role of serotonergic fibers
  Journal of Neural Transmission, 1145--1156, Vol: 125, (2018), doi: 10.1007/s00702-018-1871-7
• Elise Mètèreau, Maude Beaudoin-Gobert, Sandra Duperrier, Stèphane Thobois, Lèon Tremblay, Vèronique Sgambato-Faure
  Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey
  Movement Disorders, 298--309, Vol: 33, (2017), doi: 10.1002/mds.27201
• Maude Beaudoin-Gobert, Justine Epinat, Elise Mètèreau, Sandra Duperrier, Sara Neumane, Bènèdicte Ballanger, Franck Lavenne, François Liger, Christian Tourvielle, Frèdèric Bonnefoi, Nicolas Costes, Didier Le Bars, Emmanuel Broussolle, Stèphane Thobois, Lèon Tremblay, Vèronique Sgambato-Faure
  Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate
  Brain, 2632--2647, Vol: 138, (2015), doi: 10.1093/brain/awv183